You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Long-term β interferon in MS: safe, but what effect on disability?

https://doi.org/10.1136/jnnp.2010.208017

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Linked articles 204123

    • Competing interests NJS has received honoraria and research support from Bayer Schering, Biogen, Serono, and Teva.

    • Provenance and peer review Commissioned; not externally peer reviewed.

    Linked Articles